{"id":"https://openalex.org/W2331064409","doi":"https://doi.org/10.1097/01.qai.0000456125.43666.46","title":"D-104 Structure, immune recognition, and conformational stabilization of the HIV-1 viral spike","display_name":"D-104 Structure, immune recognition, and conformational stabilization of the HIV-1 viral spike","publication_year":2014,"publication_date":"2014-10-18","ids":{"openalex":"https://openalex.org/W2331064409","doi":"https://doi.org/10.1097/01.qai.0000456125.43666.46","mag":"2331064409"},"language":"en","primary_location":{"id":"doi:10.1097/01.qai.0000456125.43666.46","doi":"https://doi.org/10.1097/01.qai.0000456125.43666.46","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000456125.43666.46","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043677118","display_name":"Peter D. Kwong","orcid":"https://orcid.org/0000-0003-3560-232X","observed_orcids":["https://orcid.org/0000-0003-3560-232X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4405268911","display_name":"Vaccine Research Center","ror":"https://ror.org/02fve6a73","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405268911"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Peter Kwong","raw_affiliation_strings":["Vaccine Research Center, National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine Research Center, National Institutes of Health","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4405268911"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5043677118"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4405268911"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"67","issue":"Supplement 3","first_page":"56","last_page":"56"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-env-trimer","display_name":"HIV-1 Env trimer","score":0.8740000128746033},{"id":"https://openalex.org/keywords/antibody-escape","display_name":"antibody escape","score":0.5019999742507935},{"id":"https://openalex.org/keywords/n-glycosylation","display_name":"N-glycosylation","score":0.8610000014305115},{"id":"https://openalex.org/keywords/glycan-shield","display_name":"glycan shield","score":0.921999990940094},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.492000013589859},{"id":"https://openalex.org/keywords/structure-based-vaccine-design","display_name":"structure-based vaccine design","score":0.6899999976158142},{"id":"https://openalex.org/keywords/hiv-1-vaccine","display_name":"HIV-1 vaccine","score":0.6010000109672546},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.5830000042915344},{"id":"https://openalex.org/keywords/conformational-stabilization","display_name":"conformational stabilization","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C2781390188","wikidata":"https://www.wikidata.org/wiki/Q25203449","display_name":"Spike (software development)","level":2,"score":0.6485954523086548},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5930330753326416},{"id":"https://openalex.org/C103038307","wikidata":"https://www.wikidata.org/wiki/Q6556360","display_name":"Lipid bilayer fusion","level":3,"score":0.5224113464355469},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.488839328289032},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.48838943243026733},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.4783705770969391},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.47585293650627136},{"id":"https://openalex.org/C206212055","wikidata":"https://www.wikidata.org/wiki/Q2553138","display_name":"Glycan","level":3,"score":0.4664093255996704},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.44615745544433594},{"id":"https://openalex.org/C47701112","wikidata":"https://www.wikidata.org/wiki/Q735188","display_name":"Protein structure","level":2,"score":0.4385555386543274},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43593576550483704},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43182167410850525},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.37448593974113464},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34183329343795776},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.30382561683654785},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2737639546394348},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.2711672782897949},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1662585735321045},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14576831459999084},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11414209008216858},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10192301869392395},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.08918049931526184},{"id":"https://openalex.org/C115903868","wikidata":"https://www.wikidata.org/wiki/Q80993","display_name":"Software engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.qai.0000456125.43666.46","doi":"https://doi.org/10.1097/01.qai.0000456125.43666.46","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000456125.43666.46","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.504800021648407}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2074179519","https://openalex.org/W2557269322","https://openalex.org/W2903551302","https://openalex.org/W2594818536","https://openalex.org/W2898983186","https://openalex.org/W2548591449","https://openalex.org/W2040064804","https://openalex.org/W3197664886","https://openalex.org/W2138875004","https://openalex.org/W2606163836"],"abstract_inverted_index":{"The":[0,68],"HIV-1-Env":[1],"spike":[2,31,69],"is":[3],"a":[4,54,80],"marvel":[5],"of":[6,20,26,42,53,79,89,103,116,143,171],"immune":[7],"evasion.":[8],"Despite":[9],"its":[10,43,167],"exposed":[11],"position":[12],"on":[13,175],"the":[14,18,24,29,51,86,90,113,117,120,128,139,152,163,172],"viral":[15],"surface":[16],"and":[17,62,99,106,141],"elicitation":[19],"narrow-breadth":[21],"antibodies":[22,60],"throughout":[23],"course":[25],"natural":[27],"infection,":[28],"evolving":[30],"manages":[32],"to":[33,47,77,161],"evade":[34],"antibody-mediated":[35],"neutralization.":[36],"To":[37],"provide":[38],"an":[39],"atomic-level":[40,153],"understand":[41],"evasion":[44],"(and":[45],"ways":[46],"overcome),":[48],"we":[49,159],"determined":[50],"structure":[52,88,154,174],"soluble":[55],"trimeric":[56],"HIV-1-Env,":[57],"in":[58,127,166],"complex":[59],"PGT122":[61],"35O22":[63],"at":[64],"3.5":[65],"\u00c5":[66],"resolution.":[67],"structure,":[70],"which":[71,158],"single":[72],"molecule":[73],"FRET":[74],"analysis":[75,133],"indicated":[76,93],"be":[78,125,180],"prefusion":[81,87],"mature":[82],"near-native":[83,164],"conformation,":[84],"revealed":[85],"gp41":[91],"subunit,":[92],"structural":[94],"rearrangements":[95],"required":[96],"for":[97],"entry,":[98],"provided":[100],"aggregate":[101],"parameters":[102],"N-linked":[104,110],"glycosylation":[105,111],"sequence":[107],"variation.":[108],"While":[109],"covers":[112],"membrane-distal":[114],"apex":[115],"spike,":[118],"nearer":[119],"membrane,":[121],"substantial":[122],"\u201choles\u201d":[123],"can":[124],"seen":[126],"assemble":[129],"glycan":[130],"shield.":[131],"Serologic":[132],"from":[134],"chronic":[135],"cohorts,":[136],"meanwhile,":[137],"provides":[138],"prevalence":[140],"location":[142],"Env":[144],"regions":[145],"recognized":[146],"by":[147],"elicited":[148],"neutralizing":[149],"antibodies.":[150],"Further,":[151],"enabled":[155],"structure-based":[156],"design,":[157],"used":[160],"stabilize":[162],"state":[165],"antibody-bound":[168],"conformation.":[169],"Implications":[170],"trimer":[173],"HIV-1":[176],"vaccine":[177],"design":[178],"will":[179],"discussed.":[181]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}